Selma Bouden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Selma Bouden has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Leila Rouached
Department of Rheumatology, Charles Nicolle Hospital, Tunis, Tunisia
12 shared publications - Leila Abdelmoula
Department of Rheumatology, Charles Nicolle Hospital, Tunis, Tunisia
10 shared publications - Aicha Ben Tekaya
Rheumatology department, Charles Nicolle hospital, Tunis, Tunisia
9 shared publications - Ines Mahmoud
Department of Rheumatology, Charles Nicolle Hospital, Tunis, Tunisia
9 shared publications - Olfa Saidane
Department of Rheumatology, Charles Nicolle Hospital, Tunis, Tunisia
9 shared publications - Raoudha Tekaya
Department of Rheumatology, Charles Nicolle Hospital, Tunis, Tunisia
9 shared publications
Latest Publications
- Open Access
- 20 July 2026
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 53 (1) , 62
Clinical, biochemical, and radiological features of osteomalacia: evaluation of diagnostic approaches in a retrospective study of 33 cases
Introduction: Osteomalacia is a generalized bone disorder characterized by defective bone mineralization. Definitive etiological diagnoses of osteomalacia remain challenging and are not fully standardized. We aim to describe clinical, biochemical, and radiographic features, elucidate the utility of various diagnosis methods, and propose a diagnostic strategy. Methods: A retrospective study involving 33 patients with osteomalacia over a 15-year period at our Rheumatology Department. Results: The mean age was 50.6 years (range: 17-87 years), with a female predominance (sex-ratio=0.18). Clinical signs included bone pain (87.8%), gait disturbance (63.6%), motor deficit (54.5%), clinically apparent bone deformity (21.2%), fragility fracture (24.2%), and muscle pain (42.2%). Radiologically, diffuse bone demineralization was observed in 91% of patients. Other signs included Looser Milkman streaks (60.6%), bone deformities (39.5%), and bone fractures (55%). Low bone mineral density was observed in 85% of tested patients while 60% of them had densitometric osteoporosis. Main biochemical disorders included increased alkaline phosphatase levels (85%), hypocalcemia (88%), and hypophosphatemia (61%). Parathyroid hormone levels were elevated in 82% of cases, 25-hydroxyvitamin D level was reduced in all cases. All patients in our study fulfilled both the McKenna and the Adrar indexes for osteomalacia diagnosis. Both diagnostic indexes were significantly and positively correlated (r=0.56, p=0.01). Vitamin D-related osteomalacia was the predominant etiology, with vitamin D malabsorption observed in nine patients, seven of whom had celiac disease. Chronic kidney failure was observed in five cases. Osteomalacia was associated with renal phosphate leak in four cases. Conclusion: The presentation and etiologies of osteomalacia are diverse. Diagnosis relies on clinical, biochemical, and radiological findings and can be aided by diagnostic indexes such as McKenna's and Adrar's. Bone biopsy should be reserved for cases where the diagnosis is doubtful.
- 20 July 2026
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 53 (1) , 62
Open AccessClinical, biochemical, and radiological features of osteomalacia: evaluation of diagnostic approaches in a retrospective study of 33 cases
Introduction: Osteomalacia is a generalized bone disorder characterized by defective bone mineralization. Definitive etiological diagnoses of osteomalacia remain challenging and are not fully standardized. We aim to describe clinical, biochemical, and radiographic features, elucidate the utility of various diagnosis methods, and propose a diagnostic strategy. Methods: A retrospective study involving 33 patients with osteomalacia over a 15-year period at our Rheumatology Department. Results: The mean age was 50.6 years (range: 17-87 years), with a female predominance (sex-ratio=0.18). Clinical signs included bone pain (87.8%), gait disturbance (63.6%), motor deficit (54.5%), clinically apparent bone deformity (21.2%), fragility fracture (24.2%), and muscle pain (42.2%). Radiologically, diffuse bone demineralization was observed in 91% of patients. Other signs included Looser Milkman streaks (60.6%), bone deformities (39.5%), and bone fractures (55%). Low bone mineral density was observed in 85% of tested patients while 60% of them had densitometric osteoporosis. Main biochemical disorders included increased alkaline phosphatase levels (85%), hypocalcemia (88%), and hypophosphatemia (61%). Parathyroid hormone levels were elevated in 82% of cases, 25-hydroxyvitamin D level was reduced in all cases. All patients in our study fulfilled both the McKenna and the Adrar indexes for osteomalacia diagnosis. Both diagnostic indexes were significantly and positively correlated (r=0.56, p=0.01). Vitamin D-related osteomalacia was the predominant etiology, with vitamin D malabsorption observed in nine patients, seven of whom had celiac disease. Chronic kidney failure was observed in five cases. Osteomalacia was associated with renal phosphate leak in four cases. Conclusion: The presentation and etiologies of osteomalacia are diverse. Diagnosis relies on clinical, biochemical, and radiological findings and can be aided by diagnostic indexes such as McKenna's and Adrar's. Bone biopsy should be reserved for cases where the diagnosis is doubtful.
- 10 July 2026
- Published by Elsevier in Fisioterapia
- Vol. 48 (5) , 180-185
Effect of neural mobilization in patients with cervico-brachial neuralgia: A randomized controlled study
- 10 July 2026
- Published by Elsevier in Fisioterapia
- Vol. 48 (5) , 180-185
Effect of neural mobilization in patients with cervico-brachial neuralgia: A randomized controlled study
- 16 April 2026
- Published by Taylor & Francis in Archives of Environmental & Occupational Health
- Vol. 81 (5-6) , 105-112
Impact of an ergonomic training program on musculoskeletal disorders among paramedical staff: A comparative study
Musculoskeletal disorders (MSDs) are a major occupational health concern among paramedical staff, leading to pain, reduced performance, and absenteeism. This prospective interventional comparative study included all 80 paramedical staff members at the center who met the inclusion criteria, making the study population exhaustive. Participants were assigned to an intervention group (n = 40) receiving a three-session ergonomic training program or a control group (n = 40) receiving usual practice. Primary outcomes were MSD prevalence and absenteeism; the secondary outcome was quality of life (SF-36). Assessments were conducted at baseline (T0) and 6 months (T6). After 6 months, the intervention group reported a significant reduction in MSD prevalence in the cervical spine (from 55% to 30%, p = 0.01), shoulders (55% to 35%, p = 0.03), hands (40% to 20%, p = 0.008), and fingers (35% to 20%, p = 0.03) compared to baseline and to the control group. Absenteeism days decreased significantly in the intervention group (from 14 ± 7 to 8 ± 4 days, p = 0.03). No significant change was observed in overall SF-36 scores. The ergonomic training program was associated with reductions in MSD prevalence and absenteeism among paramedical staff.
- 16 April 2026
- Published by Taylor & Francis in Archives of Environmental & Occupational Health
- Vol. 81 (5-6) , 105-112
Impact of an ergonomic training program on musculoskeletal disorders among paramedical staff: A comparative study
Musculoskeletal disorders (MSDs) are a major occupational health concern among paramedical staff, leading to pain, reduced performance, and absenteeism. This prospective interventional comparative study included all 80 paramedical staff members at the center who met the inclusion criteria, making the study population exhaustive. Participants were assigned to an intervention group (n = 40) receiving a three-session ergonomic training program or a control group (n = 40) receiving usual practice. Primary outcomes were MSD prevalence and absenteeism; the secondary outcome was quality of life (SF-36). Assessments were conducted at baseline (T0) and 6 months (T6). After 6 months, the intervention group reported a significant reduction in MSD prevalence in the cervical spine (from 55% to 30%, p = 0.01), shoulders (55% to 35%, p = 0.03), hands (40% to 20%, p = 0.008), and fingers (35% to 20%, p = 0.03) compared to baseline and to the control group. Absenteeism days decreased significantly in the intervention group (from 14 ± 7 to 8 ± 4 days, p = 0.03). No significant change was observed in overall SF-36 scores. The ergonomic training program was associated with reductions in MSD prevalence and absenteeism among paramedical staff.
- Open Access
- 26 March 2026
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 64 (2) , 132-138
Neuropathic pain in rheumatoid arthritis: prevalence and associated factors
Introduction: This study aimed to assess the prevalence of neuropathic pain in rheumatoid arthritis (RA) patients, and to identify associated factors. Material and methods: We conducted a cross-sectional study in patients with RA. Neuropathic pain was evaluated using the DN4 (Douleur Neuropathique 4) and PainDETECT scores. Agreement between the 2 questionnaires was estimated through Cohen’s k. Factors associated with neuropathic pain were assessed. Results: A total of 121 patients with RA were included, with a mean age of 57 ±12.2 years, and a predominance of women (83%). The mean duration of RA was 16 ±1.0 years. The mean Disease Activity Score in 28 joints (DAS28) was 4.28 ±1.0, indicating moderate activity of the RA. According to the DN4 score, 61.2% of patients had neuropathic pain, and according to the PainDETECT score, 47.1% of patients were identified as having possible or likely neuropathic pain. Eighty-four patients (69.4%) had a positive DN4 score and/or a positive PainDETECT score. The coefficient of agreement k between the 2 tests was 0.233, indicating a fair agreement. Factors significantly associated with the presence of neuropathic pain were: female sex (p = 0.01), prolonged morning stiffness duration (p = 0.01), number of painful joints (p = 0.01), and number of swollen joints (p = 0.03). Additionally, the use of glucocorticosteroids (p = 0.001), analgesics (p = 0.03) and anti-CD20 drugs (p = 0.03) were significantly associated with neuropathic. Conclusions: Our study suggests a potentially high prevalence of neuropathic pain in patients with RA, highlighting the need for early detection and appropriate management.
- 26 March 2026
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 64 (2) , 132-138
Open AccessNeuropathic pain in rheumatoid arthritis: prevalence and associated factors
Introduction: This study aimed to assess the prevalence of neuropathic pain in rheumatoid arthritis (RA) patients, and to identify associated factors. Material and methods: We conducted a cross-sectional study in patients with RA. Neuropathic pain was evaluated using the DN4 (Douleur Neuropathique 4) and PainDETECT scores. Agreement between the 2 questionnaires was estimated through Cohen’s k. Factors associated with neuropathic pain were assessed. Results: A total of 121 patients with RA were included, with a mean age of 57 ±12.2 years, and a predominance of women (83%). The mean duration of RA was 16 ±1.0 years. The mean Disease Activity Score in 28 joints (DAS28) was 4.28 ±1.0, indicating moderate activity of the RA. According to the DN4 score, 61.2% of patients had neuropathic pain, and according to the PainDETECT score, 47.1% of patients were identified as having possible or likely neuropathic pain. Eighty-four patients (69.4%) had a positive DN4 score and/or a positive PainDETECT score. The coefficient of agreement k between the 2 tests was 0.233, indicating a fair agreement. Factors significantly associated with the presence of neuropathic pain were: female sex (p = 0.01), prolonged morning stiffness duration (p = 0.01), number of painful joints (p = 0.01), and number of swollen joints (p = 0.03). Additionally, the use of glucocorticosteroids (p = 0.001), analgesics (p = 0.03) and anti-CD20 drugs (p = 0.03) were significantly associated with neuropathic. Conclusions: Our study suggests a potentially high prevalence of neuropathic pain in patients with RA, highlighting the need for early detection and appropriate management.
- Open Access
- 11 November 2025
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 63 (5) , 337-347
Efficacy and safety of anti-interleukin-6 treatment in familial Mediterranean fever: a systematic literature review
Introduction: Biological treatments are indicated in familial Mediterranean fever (FMF) patients with colchicine resistance or intolerance. Interleukin-1 (IL-1) inhibitors may not yield sufficient efficacy and safety. Interleukin-6 inhibitors (tocilizumab – TCZ) have been suggested to be potentially beneficial. This systematic literature review aimed to evaluate the existing data on the efficacy and safety of IL-6 inhibitors in the treatment of FMF. Material and Methods: A systematic literature review was conducted using PubMed, Embase, Scopus, Web of Science, and the Cochrane Library to identify literature published until February 2024 on “Tocilizumab” OR “Interleukin-6 inhibitor” AND “Familial Mediterranean Fever”. This study was conducted according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Results: A total of 11 studies were included, corresponding to 68 patients: 6 studies were case reports, 3 were case series, and 2 were randomized control trials. Tocilizumab was indicated mainly for amyloid A (AA) amyloidosis and resistance/intolerance to other drugs. Tocilizumab showed efficacy in controlling FMF attacks and disease symptoms including fever, abdominal pain, arthritis and arthralgia. Inflammatory markers including C-reactive protein and serum amyloid A protein decreased. A decrease in proteinuria levels was reported in 20 patients. Adverse events were recorded in one-third of patients and led to TCZ discontinuation in 5 patients. No deaths associated with anti-IL-6 treatment were documented within a median follow-up period of 13 months. Conclusions: Although the duration of follow-up of TCZ was short, we concluded that TCZ might present an acceptable profile regarding efficacy and safety in adult FMF patients. Our data suggest that TCZ could be a good treatment option after IL-1 inhibitors and warrants further investigation.
- 11 November 2025
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 63 (5) , 337-347
Open AccessEfficacy and safety of anti-interleukin-6 treatment in familial Mediterranean fever: a systematic literature review
Introduction: Biological treatments are indicated in familial Mediterranean fever (FMF) patients with colchicine resistance or intolerance. Interleukin-1 (IL-1) inhibitors may not yield sufficient efficacy and safety. Interleukin-6 inhibitors (tocilizumab – TCZ) have been suggested to be potentially beneficial. This systematic literature review aimed to evaluate the existing data on the efficacy and safety of IL-6 inhibitors in the treatment of FMF. Material and Methods: A systematic literature review was conducted using PubMed, Embase, Scopus, Web of Science, and the Cochrane Library to identify literature published until February 2024 on “Tocilizumab” OR “Interleukin-6 inhibitor” AND “Familial Mediterranean Fever”. This study was conducted according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Results: A total of 11 studies were included, corresponding to 68 patients: 6 studies were case reports, 3 were case series, and 2 were randomized control trials. Tocilizumab was indicated mainly for amyloid A (AA) amyloidosis and resistance/intolerance to other drugs. Tocilizumab showed efficacy in controlling FMF attacks and disease symptoms including fever, abdominal pain, arthritis and arthralgia. Inflammatory markers including C-reactive protein and serum amyloid A protein decreased. A decrease in proteinuria levels was reported in 20 patients. Adverse events were recorded in one-third of patients and led to TCZ discontinuation in 5 patients. No deaths associated with anti-IL-6 treatment were documented within a median follow-up period of 13 months. Conclusions: Although the duration of follow-up of TCZ was short, we concluded that TCZ might present an acceptable profile regarding efficacy and safety in adult FMF patients. Our data suggest that TCZ could be a good treatment option after IL-1 inhibitors and warrants further investigation.
- 19 September 2025
- Published by SAGE Publications in British Journal of Pain
- Vol. 20 (1) , 31-45
Effect of music therapy on pain in rheumatic and musculoskeletal disorders: A systematic review
Introduction: The aim of this systematic literature review was to critically analyze and synthesize the current scientific literature on the effectiveness of music therapy in reducing pain among patients with rheumatic and musculoskeletal disorders (RMDs). Methods: The literature search strategy was performed in the digital databases of MEDLINE, Scopus, and the Cochrane library to identify relevant studies published from January 2000 to December 2024, assessing the impact of music therapy on pain-related outcomes. Results: Among the included studies (n=16), 10 were randomized controlled trials (RCTs) and 6 were non-randomized studies, including 4 prospective cohort studies and 2 prospective comparative studies. Pain was most frequently assessed using the Visual Analogue Scale (VAS), and receptive music listening was the most frequently used method, with some studies incorporating additional therapeutic interventions. A total of 11 studies out of 16 reported a statistically significant decrease in pain intensity following music therapy interventions. Conversely, 5 studies reported mixed results, emphasizing the heterogeneity of populations and interventions. Conclusion: Music therapy appears to be a beneficial adjunct in pain management for patients with RMDs. However, well-designed randomized controlled trials, with larger sample sizes, are necessary to standardize intervention protocols and evaluate long-term effects.
- 19 September 2025
- Published by SAGE Publications in British Journal of Pain
- Vol. 20 (1) , 31-45
Effect of music therapy on pain in rheumatic and musculoskeletal disorders: A systematic review
Introduction: The aim of this systematic literature review was to critically analyze and synthesize the current scientific literature on the effectiveness of music therapy in reducing pain among patients with rheumatic and musculoskeletal disorders (RMDs). Methods: The literature search strategy was performed in the digital databases of MEDLINE, Scopus, and the Cochrane library to identify relevant studies published from January 2000 to December 2024, assessing the impact of music therapy on pain-related outcomes. Results: Among the included studies (n=16), 10 were randomized controlled trials (RCTs) and 6 were non-randomized studies, including 4 prospective cohort studies and 2 prospective comparative studies. Pain was most frequently assessed using the Visual Analogue Scale (VAS), and receptive music listening was the most frequently used method, with some studies incorporating additional therapeutic interventions. A total of 11 studies out of 16 reported a statistically significant decrease in pain intensity following music therapy interventions. Conversely, 5 studies reported mixed results, emphasizing the heterogeneity of populations and interventions. Conclusion: Music therapy appears to be a beneficial adjunct in pain management for patients with RMDs. However, well-designed randomized controlled trials, with larger sample sizes, are necessary to standardize intervention protocols and evaluate long-term effects.
- Open Access
- 18 March 2024
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 62 (1) , 35-42
Burden of disease, pain catastrophizing, and central sensitization in relation to work-related issues in young spondyloarthritis patients
Introduction: Spondyloarthritis (SpA) is a common rheumatic inflammatory disease and can impact patients’ work productivity. We aimed to evaluate the impact of pain catastrophizing and central sensitization on work outcomes in young SpA patients and determine the predictive factors of work productivity loss.Material and methods: We performed a cross-sectional study over 6 months. We included patients aged between 18 and 50 years old, diagnosed with axial or peripheral SpA. Pain catastrophizing and central sensitization were assessed using the Pain Catastrophizing Scale (PCS) and Central Sensitization Inventory (CSI) questionnaire, respectively. Impact of SpA on work productivity and activity impairment during and out-side of work was measured with the Work Productivity and Activity Impairment Questionnaire (WPAI: Spondyloarthritis).Results: A total of 72 patients were enrolled, with a median age of 39 years (28.3–46), 65.3% men, and 54.4% working patients. Median scores of activity impairment outside of work, and work productivity loss were 50% (40–70), and 50% (40–60), respectively. Median absenteeism and presenteeism scores were 0% (IQR 0–7), and 100% (IQR 86.5–100), respectively. Regarding work-related outcomes: activity impairment was positively correlated with CSI and PCS; presenteeism was significantly associated with male sex (p = 0.009); and work productivity loss was positively associated with anxiety, depression, and poor quality of life. Multivariate regression analysis identified predictive factors of work productivity loss: male sex, poor quality of life, and prolonged morning stiffness.Conclusions: Assessment of the impact of pain catastrophizing and central sensitization on work-related outcomes in patients with SpA is important to understand the burden of illness and to identify early those in need of interventions in clinical practice.
- 18 March 2024
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 62 (1) , 35-42
Open AccessBurden of disease, pain catastrophizing, and central sensitization in relation to work-related issues in young spondyloarthritis patients
Introduction: Spondyloarthritis (SpA) is a common rheumatic inflammatory disease and can impact patients’ work productivity. We aimed to evaluate the impact of pain catastrophizing and central sensitization on work outcomes in young SpA patients and determine the predictive factors of work productivity loss.Material and methods: We performed a cross-sectional study over 6 months. We included patients aged between 18 and 50 years old, diagnosed with axial or peripheral SpA. Pain catastrophizing and central sensitization were assessed using the Pain Catastrophizing Scale (PCS) and Central Sensitization Inventory (CSI) questionnaire, respectively. Impact of SpA on work productivity and activity impairment during and out-side of work was measured with the Work Productivity and Activity Impairment Questionnaire (WPAI: Spondyloarthritis).Results: A total of 72 patients were enrolled, with a median age of 39 years (28.3–46), 65.3% men, and 54.4% working patients. Median scores of activity impairment outside of work, and work productivity loss were 50% (40–70), and 50% (40–60), respectively. Median absenteeism and presenteeism scores were 0% (IQR 0–7), and 100% (IQR 86.5–100), respectively. Regarding work-related outcomes: activity impairment was positively correlated with CSI and PCS; presenteeism was significantly associated with male sex (p = 0.009); and work productivity loss was positively associated with anxiety, depression, and poor quality of life. Multivariate regression analysis identified predictive factors of work productivity loss: male sex, poor quality of life, and prolonged morning stiffness.Conclusions: Assessment of the impact of pain catastrophizing and central sensitization on work-related outcomes in patients with SpA is important to understand the burden of illness and to identify early those in need of interventions in clinical practice.
- 20 June 2023
- Published by Wolters Kluwer Health in Journal of Pediatric Orthopaedics B
- Vol. 33 (3) , 283-289
Efficacy and safety of intravenous Zolidronic acid in the treatment of pediatric osteogenesis imperfecta: a systematic review
Osteogenesis imperfecta is an inherited clinically heterogeneous disorder of bone metabolism characterized by bone and skeletal fragility and an increased risk of fractures. Pamidronate infusion was the standard treatment, but zoledronic acid is increasingly used to treat children with osteogenesis imperfecta. We conducted a systematic literature review to evaluate the efficacy and safety of intravenous zoledronic acid in the treatment of osteogenesis imperfecta in pediatric patients. A systematic review of the published literature was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Eligible articles were clinical trials and observational studies including pediatric patients (Z-score and femoral neck-bone mineral density Z-scores. A significant decrease in fracture rate has also been noted both in vertebral and nonvertebral fracture incidence. The two most common side effects were fever and flu-like reactions. None of the patients presented severe adverse events. Zoledronic acid appeared to be well-tolerated and effective in the treatment of pediatric osteogenesis imperfecta.
- 20 June 2023
- Published by Wolters Kluwer Health in Journal of Pediatric Orthopaedics B
- Vol. 33 (3) , 283-289
Efficacy and safety of intravenous Zolidronic acid in the treatment of pediatric osteogenesis imperfecta: a systematic review
Osteogenesis imperfecta is an inherited clinically heterogeneous disorder of bone metabolism characterized by bone and skeletal fragility and an increased risk of fractures. Pamidronate infusion was the standard treatment, but zoledronic acid is increasingly used to treat children with osteogenesis imperfecta. We conducted a systematic literature review to evaluate the efficacy and safety of intravenous zoledronic acid in the treatment of osteogenesis imperfecta in pediatric patients. A systematic review of the published literature was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Eligible articles were clinical trials and observational studies including pediatric patients (Z-score and femoral neck-bone mineral density Z-scores. A significant decrease in fracture rate has also been noted both in vertebral and nonvertebral fracture incidence. The two most common side effects were fever and flu-like reactions. None of the patients presented severe adverse events. Zoledronic acid appeared to be well-tolerated and effective in the treatment of pediatric osteogenesis imperfecta.
- 17 June 2023
- Published by Wiley in Musculoskeletal Care
- Vol. 21 (4) , 1098-1104
Psoriatic Arthritis Quality of Life questionnaire: Translation, cultural adaptation and validation into Arabic language
Background: Psoriatic arthritis (PsA) is a multifaceted inflammatory disease that has a strong negative impact on the quality of life (QoL) of patients. The Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire was the first disease‐specific patient‐derived instrument developed to measure the QoL in patients with PsA. Our objective was to translate the PsAQol into Arabic language and evaluate its reliability and validity in patients with PsA.Methods: This was a cross‐sectional study including patients with PsA. A clinical and biological assessment of the patients was performed at inclusion. The translation of the original PsAQoL into Arabic was performed by a professional bilingual and lay panel. Eight patients were interviewed to assess face and content validity. A separate sample of PsA patients (n = 30) were invited to participate in a test‐retest postal study in order to investigate reproducibility and construct validity. One week separated the two administrations. The Arabic version of Health Assessment Questionnaire (HAQ) was used as a comparator instrument for convergent validity.Results: Face and content validity were satisfactory. The Arabic version of the PsAQoL was found to be relevant, understandable and easy to complete in only a few minutes. One item was excluded (item 16). It had no correlation with either the other 19 items or the total score of PsAQol. The Arabic PsAQol had excellent internal consistency (Cronbach's a = 0.926), and test‐retest reliability (r = 0.982). There was a positive correlation between the total score of the PsAQoL and the Arabic version of HAQ (Spearman's r = 0.838, p < 10−3). Exploratory factor analysis had extracted two factors explaining 55% of the total variance.Conclusion: Nineteen items were selected to compose the Arabic version of PsAQoL, which was found to be relevant and understandable and has excellent reliability and construct validity. The new measure will be a valuable new tool for use in routine care for patients' assessment.
- 17 June 2023
- Published by Wiley in Musculoskeletal Care
- Vol. 21 (4) , 1098-1104
Psoriatic Arthritis Quality of Life questionnaire: Translation, cultural adaptation and validation into Arabic language
Background: Psoriatic arthritis (PsA) is a multifaceted inflammatory disease that has a strong negative impact on the quality of life (QoL) of patients. The Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire was the first disease‐specific patient‐derived instrument developed to measure the QoL in patients with PsA. Our objective was to translate the PsAQol into Arabic language and evaluate its reliability and validity in patients with PsA.Methods: This was a cross‐sectional study including patients with PsA. A clinical and biological assessment of the patients was performed at inclusion. The translation of the original PsAQoL into Arabic was performed by a professional bilingual and lay panel. Eight patients were interviewed to assess face and content validity. A separate sample of PsA patients (n = 30) were invited to participate in a test‐retest postal study in order to investigate reproducibility and construct validity. One week separated the two administrations. The Arabic version of Health Assessment Questionnaire (HAQ) was used as a comparator instrument for convergent validity.Results: Face and content validity were satisfactory. The Arabic version of the PsAQoL was found to be relevant, understandable and easy to complete in only a few minutes. One item was excluded (item 16). It had no correlation with either the other 19 items or the total score of PsAQol. The Arabic PsAQol had excellent internal consistency (Cronbach's a = 0.926), and test‐retest reliability (r = 0.982). There was a positive correlation between the total score of the PsAQoL and the Arabic version of HAQ (Spearman's r = 0.838, p < 10−3). Exploratory factor analysis had extracted two factors explaining 55% of the total variance.Conclusion: Nineteen items were selected to compose the Arabic version of PsAQoL, which was found to be relevant and understandable and has excellent reliability and construct validity. The new measure will be a valuable new tool for use in routine care for patients' assessment.
- 1 May 2023
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 19 (2) , 214-221
Fibromyalgia in Spondyloarthritis: Prevalence and Effect on Disease Activity and Treatment
Backgroung: Fibromyalgia may be associated to Spondyloarthritis with which it shares some common symptoms such as sleep disorders, fatigue and diffuse pain, leading to diagnostic and treatment dilemmas. Objectives: We aimed to determine the prevalence of fibromyalgia in axial spondyloarthritis and to determine how fibromyalgia might influence the assessments of disease activity and how it might impact treatment. Methods: An observational cross-sectional study was conducted. The study included 100 patients with axial spondyloarthritis according to the Assessment of SpondyloArthritis international Society criteria. Fibromyalgia was diagnosed based on the 2010 American College of Rheumatology crite-ria. Demographics, disease characteristics, activity parameters and treatment were compared be-tween patients with and without fibromyalgia. Patients were recruited from the hospitalization unit and the outpatient clinic of rheumatology. Results: The mean age of patients was 44.65 ± 13.13 years, with a sex ratio equal to 2. The preva-lence of fibromyalgia was 20%. Fibromyalgia associated factors were advanced age and a late age at the onset of axial spondyloarthritis. Disease activity parameters such as global pain VAS, BASDAI, ASDAS-ESR, ASDAS-CRP, BASFI and BAS-G as well as MASES and BASMI were significantly higher in the presence of FM. Doses of paracetamol were significantly higher among FM+ patients. Also, treatment duration of the current anti-TNF alpha agent was significantly shorter among FM+ patients. Conclusion: Our study showed that fibromyalgia was associated with axial spondyloarthritis in 20% of patients. Its presence was associated with higher disease activity parameters and negative impact on the treatment.
- 1 May 2023
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 19 (2) , 214-221
Fibromyalgia in Spondyloarthritis: Prevalence and Effect on Disease Activity and Treatment
Backgroung: Fibromyalgia may be associated to Spondyloarthritis with which it shares some common symptoms such as sleep disorders, fatigue and diffuse pain, leading to diagnostic and treatment dilemmas. Objectives: We aimed to determine the prevalence of fibromyalgia in axial spondyloarthritis and to determine how fibromyalgia might influence the assessments of disease activity and how it might impact treatment. Methods: An observational cross-sectional study was conducted. The study included 100 patients with axial spondyloarthritis according to the Assessment of SpondyloArthritis international Society criteria. Fibromyalgia was diagnosed based on the 2010 American College of Rheumatology crite-ria. Demographics, disease characteristics, activity parameters and treatment were compared be-tween patients with and without fibromyalgia. Patients were recruited from the hospitalization unit and the outpatient clinic of rheumatology. Results: The mean age of patients was 44.65 ± 13.13 years, with a sex ratio equal to 2. The preva-lence of fibromyalgia was 20%. Fibromyalgia associated factors were advanced age and a late age at the onset of axial spondyloarthritis. Disease activity parameters such as global pain VAS, BASDAI, ASDAS-ESR, ASDAS-CRP, BASFI and BAS-G as well as MASES and BASMI were significantly higher in the presence of FM. Doses of paracetamol were significantly higher among FM+ patients. Also, treatment duration of the current anti-TNF alpha agent was significantly shorter among FM+ patients. Conclusion: Our study showed that fibromyalgia was associated with axial spondyloarthritis in 20% of patients. Its presence was associated with higher disease activity parameters and negative impact on the treatment.